ELUT

SEC source: 0001104659-23-037129 · tm2310663-1_4seq1.xml · nonDerivative · entry 3

Birchview Capital, LP · CIK 0001618205 · 10% owner

Birchview Fund LLC · CIK 0001603544 · 10% owner

Strobeck Matthew · CIK 0001377832 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,643,184

F1 · ownership.nature: Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC ("the Fund"). Birchview Capital, LP is the investment manager of the Fund.

F2 · ownership.nature: The Fund acquired the shares as specified in Table I. As investment manager of the Fund, Birchview Capital, LP possesses the power to vote and dispose or direct the disposition of the shares acquired by the Fund.

SEC source: 0001104659-24-025392 · tm246490-2_4aseq1.xml · nonDerivative · entry 4

Birchview Capital, LP · CIK 0001618205 · 10% owner in previous filing

Birchview Fund LLC · CIK 0001603544 · 10% owner in previous filing

Strobeck Matthew · CIK 0001377832 · 10% owner in previous filing

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,645,184

F1 · ownership.nature: Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC ("the Fund"). Birchview Capital, LP is the investment manager of the Fund.

F3 · ownership.nature: As specified in Table I, Birchview Capital, LP advises the acquired shares in a separately managed account ("SMA").

SEC source: 0001104659-24-025392 · tm246490-2_4aseq1.xml · nonDerivative · entry 3

Birchview Capital, LP · CIK 0001618205 · 10% owner in previous filing

Birchview Fund LLC · CIK 0001603544 · 10% owner in previous filing

Strobeck Matthew · CIK 0001377832 · 10% owner in previous filing

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,643,184

F1 · ownership.nature: Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC ("the Fund"). Birchview Capital, LP is the investment manager of the Fund.

F2 · ownership.nature: The Fund acquired the shares as specified in Table I. As investment manager of the Fund, Birchview Capital, LP possesses the power to vote and dispose or direct the disposition of the shares acquired by the Fund.

SEC source: 0001104659-23-037129 · tm2310663-1_4seq1.xml · nonDerivative · entry 2

Birchview Capital, LP · CIK 0001618205 · 10% owner

Birchview Fund LLC · CIK 0001603544 · 10% owner

Strobeck Matthew · CIK 0001377832 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,625,184

F1 · ownership.nature: Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC ("the Fund"). Birchview Capital, LP is the investment manager of the Fund.

F3 · ownership.nature: As specified in Table I, Birchview Capital, LP advises the acquired shares in a separately managed account ("SMA").

SEC source: 0001104659-23-037129 · tm2310663-1_4seq1.xml · nonDerivative · entry 1

Birchview Capital, LP · CIK 0001618205 · 10% owner

Birchview Fund LLC · CIK 0001603544 · 10% owner

Strobeck Matthew · CIK 0001377832 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,615,184

F1 · ownership.nature: Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC ("the Fund"). Birchview Capital, LP is the investment manager of the Fund.

F2 · ownership.nature: The Fund acquired the shares as specified in Table I. As investment manager of the Fund, Birchview Capital, LP possesses the power to vote and dispose or direct the disposition of the shares acquired by the Fund.

SEC source: 0001104659-24-025392 · tm246490-2_4aseq1.xml · nonDerivative · entry 2

Birchview Capital, LP · CIK 0001618205 · 10% owner in previous filing

Birchview Fund LLC · CIK 0001603544 · 10% owner in previous filing

Strobeck Matthew · CIK 0001377832 · 10% owner in previous filing

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,625,184

F1 · ownership.nature: Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC ("the Fund"). Birchview Capital, LP is the investment manager of the Fund.

F3 · ownership.nature: As specified in Table I, Birchview Capital, LP advises the acquired shares in a separately managed account ("SMA").

SEC source: 0001104659-24-025392 · tm246490-2_4aseq1.xml · nonDerivative · entry 1

Birchview Capital, LP · CIK 0001618205 · 10% owner in previous filing

Birchview Fund LLC · CIK 0001603544 · 10% owner in previous filing

Strobeck Matthew · CIK 0001377832 · 10% owner in previous filing

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 1,615,184

F1 · ownership.nature: Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC ("the Fund"). Birchview Capital, LP is the investment manager of the Fund.

F2 · ownership.nature: The Fund acquired the shares as specified in Table I. As investment manager of the Fund, Birchview Capital, LP possesses the power to vote and dispose or direct the disposition of the shares acquired by the Fund.

SEC source: 0001415889-23-004626 · form4-03102023_020301.xml · nonDerivative · entry 2

Englese Thomas · CIK 0001825799 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,917

F2 · kind: Represents shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.

SEC source: 0001415889-23-004624 · form4-03102023_020359.xml · derivative · entry 2

Ferguson Matthew · CIK 0001304079 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,575

Underlying: Class A Common Stock · 1,287 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units.

F2 · derivative.exercise_date: On March 8, 2021, the Reporting Person was granted 5,150 restricted stock units, vesting in four substantially equal annual installments beginning on March 8, 2022.

F2 · derivative.expiration_date: On March 8, 2021, the Reporting Person was granted 5,150 restricted stock units, vesting in four substantially equal annual installments beginning on March 8, 2022.

SEC source: 0001415889-23-004624 · form4-03102023_020359.xml · nonDerivative · entry 1

Ferguson Matthew · CIK 0001304079 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,504

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units.

SEC source: 0001415889-23-004626 · form4-03102023_020301.xml · derivative · entry 3

Englese Thomas · CIK 0001825799 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,875

Underlying: Class A Common Stock · 937 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of the restricted stock units ("RSUs").

F3 · derivative.exercise_date: On March 8, 2021, the Reporting Person was granted 3,750 RSUs, vesting in four substantially equal annual installments beginning on March 8, 2022.

F3 · derivative.expiration_date: On March 8, 2021, the Reporting Person was granted 3,750 RSUs, vesting in four substantially equal annual installments beginning on March 8, 2022.

SEC source: 0001415889-23-004626 · form4-03102023_020301.xml · nonDerivative · entry 1

Englese Thomas · CIK 0001825799 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,206

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of the restricted stock units ("RSUs").

SEC source: 0001415889-22-013020 · form4-12272022_111257.xml · derivative · entry 1

HighCape Capital, L.P. · CIK 0001826279 · Director · 10% owner

HIGHCAPE PARTNERS, L.P. · CIK 0001598046 · 10% owner

HIGHCAPE PARTNERS QP, L.P. · CIK 0001598026 · 10% owner

HighCape Partners GP, LLC · CIK 0001819933 · 10% owner

HighCape Partners GP, L.P. · CIK 0001819932 · 10% owner

HighCape Co-Investment Vehicle I, LLC · CIK 0001819988 · 10% owner

HighCape Co-Investment Vehicle II, LLC · CIK 0001820044 · Director · 10% owner

HighCape Capital, LLC · CIK 0001827500 · 10% owner

Zuga Matt · CIK 0001790214 · Director · 10% owner

RAKIN KEVIN · CIK 0001184421 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 17,533

Underlying: Class A Common Stock · 17,533 shares

Expires 2032-12-21

F1 · derivative.exercise_date: This option vests in full and shall be fully exercisable on June 20, 2023, subject to Mr. Rakin's continuing in service on the Issuer's board of directors through the vesting date.

F2 · ownership.nature: Granted to Kevin L. Rakin as non-employee member of the Issuer's board of directors.

SEC source: 0001415889-22-013047 · form4-12282022_081221.xml · derivative · entry 1

HighCape Partners GP II, LLC · CIK 0001957360 · 10% owner

HighCape Partners GP II, L.P. · CIK 0001957359 · 10% owner

HighCape Partners QP II, L.P. · CIK 0001770972 · 10% owner

HighCape Partners II, L.P. · CIK 0001770952 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 17,533

Underlying: Class A Common Stock · 17,533 shares

Expires 2032-12-21

F1 · derivative.exercise_date: This option vests in full and shall be fully exercisable on June 20, 2023, subject to Mr. Rakin's continuing in service on the Issuer's board of directors through the vesting date.

F2 · ownership.nature: Granted to Kevin L. Rakin as non-employee member of the Issuer's board of directors.

SEC source: 0001415889-22-012640 · form4-12162022_091245.xml · nonDerivative · entry 1

Colpman David · CIK 0001818776 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,098

SEC source: 0001415889-22-012417 · form4-12122022_101207.xml · nonDerivative · entry 1

Makes Brigid · CIK 0001375927 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000

SEC source: 0001104659-23-019991 · tm236492-1_4seq1.xml · nonDerivative · entry 6

Birchview Capital, LP · CIK 0001618205 · 10% owner

Birchview Fund LLC · CIK 0001603544 · 10% owner

Strobeck Matthew · CIK 0001377832 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,515,184

F1 · ownership.nature: Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC ("the Fund"). Birchview Capital, LP is the investment manager of the Fund.

F4 · ownership.nature: As specified in Table I, Birchview Capital, LP advises the shares in a different SMA other than the one noted above.

SEC source: 0001104659-23-019991 · tm236492-1_4seq1.xml · nonDerivative · entry 5

Birchview Capital, LP · CIK 0001618205 · 10% owner

Birchview Fund LLC · CIK 0001603544 · 10% owner

Strobeck Matthew · CIK 0001377832 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,511,184

F1 · ownership.nature: Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC ("the Fund"). Birchview Capital, LP is the investment manager of the Fund.

F3 · ownership.nature: As specified in Table I, Birchview Capital, LP advises the shares in a separately managed account ("SMA").

SEC source: 0001104659-23-019991 · tm236492-1_4seq1.xml · nonDerivative · entry 4

Birchview Capital, LP · CIK 0001618205 · 10% owner

Birchview Fund LLC · CIK 0001603544 · 10% owner

Strobeck Matthew · CIK 0001377832 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,502,123

F1 · ownership.nature: Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC ("the Fund"). Birchview Capital, LP is the investment manager of the Fund.

F3 · ownership.nature: As specified in Table I, Birchview Capital, LP advises the shares in a separately managed account ("SMA").

SEC source: 0001104659-23-019991 · tm236492-1_4seq1.xml · nonDerivative · entry 3

Birchview Capital, LP · CIK 0001618205 · 10% owner

Birchview Fund LLC · CIK 0001603544 · 10% owner

Strobeck Matthew · CIK 0001377832 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,468,123

F1 · ownership.nature: Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC ("the Fund"). Birchview Capital, LP is the investment manager of the Fund.

F2 · ownership.nature: The Fund acquired the shares as specified in Table I. As investment manager of the Fund, Birchview Capital, LP possesses the power to vote and dispose or direct the disposition of the shares acquired by the Fund.

SEC source: 0001415889-22-012089 · form4-12062022_011258.xml · nonDerivative · entry 3

Ferguson Matthew · CIK 0001304079 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,217

F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.56 to $3.65. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001415889-22-012089 · form4-12062022_011258.xml · nonDerivative · entry 2

Ferguson Matthew · CIK 0001304079 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,217

SEC source: 0001104659-22-125197 · tm2232148-1_4seq1.xml · nonDerivative · entry 1

HighCape Capital, L.P. · CIK 0001826279 · Director · 10% owner

HIGHCAPE PARTNERS, L.P. · CIK 0001598046 · 10% owner

HIGHCAPE PARTNERS QP, L.P. · CIK 0001598026 · 10% owner

HighCape Partners GP, LLC · CIK 0001819933 · 10% owner

HighCape Partners GP, L.P. · CIK 0001819932 · 10% owner

HighCape Co-Investment Vehicle I, LLC · CIK 0001819988 · 10% owner

HighCape Co-Investment Vehicle II, LLC · CIK 0001820044 · 10% owner

HighCape Capital, LLC · CIK 0001827500 · 10% owner

Zuga Matt · CIK 0001790214 · Director · 10% owner

RAKIN KEVIN · CIK 0001184421 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 5,597,604

F1 · ownership.nature: Includes: (i) 53,818 shares of Class A Common Stock held of record by HighCape Partners, L.P.; (ii) 4,001,428 shares of Class A Common Stock held of record by HighCape Partners QP, L.P.; (iii) 499,145 shares of Class A Common Stock held of record by HighCape Co-Investment Vehicle I, LLC; (iv) 259,282 shares of Class A Common Stock held of record by HighCape Co-Investment Vehicle II, LLC; (v) 48,931 shares of Class A Common Stock held of record by HighCape Capital, L.P.; (vi) 15,023 shares of Class A Common Stock held of record by HighCape Partners II, L.P.; and (vii) 719,977 shares of Class A Common Stock held of record by HighCape Partners QP II, L.P.

F2 · ownership.nature: Kevin Rakin and W. Matthew Zuga, members of Issuer's board of directors, are the managing members of HighCape Partners GP, LLC, which is the general partner of HighCape Partners GP, L.P., which is the general partner of each of HighCape Partners, L.P. and HighCape Partners QP, L.P. Messrs. Rakin and Zuga are the managing members of HighCape Capital, LLC, which is the general partner of HighCape Capital, L.P. Messrs. Rakin and Zuga are also the managing members of HighCape Partners GP II, LLC, which is the general partner of HighCape Partners GP II, L.P., which is the general partner of each of HighCape Partners II, L.P. and HighCape Partners QP II, L.P.

F3 · ownership.nature: Each of Mr. Rakin, Mr. Zuga, HighCape Partners GP, LLC and HighCape Partners GP, L.P. may be deemed to beneficially own the securities held of record by each of HighCape Partners, L.P. and HighCape Partners QP, L.P. Each of Mr. Rakin, Mr. Zuga and HighCape Capital, LLC may be deemed to beneficially own the securities held of record by HighCape Capital, L.P. Each of Mr. Rakin, Mr. Zuga, HighCape Partners GP II, LLC and HighCape Partners GP II, L.P. may be deemed to beneficially own the securities held of record by each of HighCape Partners II, L.P. and HighCape Partners QP II, L.P.

F4 · ownership.nature: In addition, Mr. Zuga is the managing member of each of HighCape Co-Investment Vehicle I, LLC and HighCape Co-Investment Vehicle II, LLC and may be deemed to beneficially own the securities held of record by each such entity. Mr. Rakin may be deemed to beneficially own the securities held of record by the Kevin L. Rakin Irrevocable Trust. Each of the reporting persons disclaims beneficial ownership of the securities held by the other reporting persons except to the extent of each reporting person's pecuniary interest therein, if any.

SEC source: 0001415889-22-012089 · form4-12062022_011258.xml · nonDerivative · entry 1

Ferguson Matthew · CIK 0001304079 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,217

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.00 to $4.05. The reporting person undertakes to provide Aziyo Biologics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001104659-23-019991 · tm236492-1_4seq1.xml · nonDerivative · entry 2

Birchview Capital, LP · CIK 0001618205 · 10% owner

Birchview Fund LLC · CIK 0001603544 · 10% owner

Strobeck Matthew · CIK 0001377832 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,458,123

F1 · ownership.nature: Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC ("the Fund"). Birchview Capital, LP is the investment manager of the Fund.

F2 · ownership.nature: The Fund acquired the shares as specified in Table I. As investment manager of the Fund, Birchview Capital, LP possesses the power to vote and dispose or direct the disposition of the shares acquired by the Fund.

SEC source: 0001415889-22-010764 · form4-10242022_011032.xml · derivative · entry 1

Colpman David · CIK 0001818776 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,513

Underlying: Class A Common Stock · 28,513 shares

Expires 2032-10-20

F1 · derivative.exercise_date: The option vests annually in three equal installments of one-third each, on each of the first three anniversaries of the grant date, such that the option shall be fully vested and exercisable on October 20, 2025.

SEC source: 0001415889-22-010767 · form4-10242022_021031.xml · derivative · entry 1

Williams Michelle LeRoux · CIK 0001398249 · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,000

Underlying: Class A Common Stock · 90,000 shares

Expires 2032-10-20

F1 · derivative.exercise_date: The option vests as to 25% of the shares on October 20, 2023 and in 12 equal quarterly installments thereafter, such that the option shall be fully vested and exercisable on October 20, 2026.

SEC source: 0001415889-22-009542 · form4-09122022_020953.xml · derivative · entry 3

Ferguson Matthew · CIK 0001304079 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 13,874 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units.

F4 · derivative.exercise_date: The restricted stock units granted on March 8, 2022 vested in full on September 8, 2022.

F4 · derivative.expiration_date: The restricted stock units granted on March 8, 2022 vested in full on September 8, 2022.

SEC source: 0001415889-22-009542 · form4-09122022_020953.xml · nonDerivative · entry 2

Ferguson Matthew · CIK 0001304079 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,217

F3 · shares: Shares withheld by the Issuer to satisfy tax withholding requirements on vesting of restricted stock units.

SEC source: 0001415889-22-009542 · form4-09122022_020953.xml · nonDerivative · entry 1

Ferguson Matthew · CIK 0001304079 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,015

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units.

F2 · balance_after: Includes one share of the Issuer's Class A Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan.

SEC source: 0001415889-22-009538 · form4-09122022_020936.xml · derivative · entry 3

Englese Thomas · CIK 0001825799 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 15,390 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units.

F3 · derivative.exercise_date: The restricted stock units granted on March 8, 2022 vested in full on September 8, 2022.

F3 · derivative.expiration_date: The restricted stock units granted on March 8, 2022 vested in full on September 8, 2022.

SEC source: 0001415889-22-009538 · form4-09122022_020936.xml · nonDerivative · entry 2

Englese Thomas · CIK 0001825799 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,269

F2 · shares: Shares withheld by the Issuer to satisfy tax withholding requirements on vesting of restricted stock units.

SEC source: 0001415889-22-009538 · form4-09122022_020936.xml · nonDerivative · entry 1

Englese Thomas · CIK 0001825799 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,997

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units.

SEC source: 0001415889-22-009540 · form4-09122022_020909.xml · derivative · entry 3

Edwards Peter G · CIK 0001578376 · GENERAL COUNSEL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 4,625 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units.

F3 · derivative.exercise_date: The restricted stock units granted on March 8, 2022 vested in full on September 8, 2022.

F3 · derivative.expiration_date: The restricted stock units granted on March 8, 2022 vested in full on September 8, 2022.

SEC source: 0001415889-22-009540 · form4-09122022_020909.xml · nonDerivative · entry 2

Edwards Peter G · CIK 0001578376 · GENERAL COUNSEL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,498

F2 · shares: Shares withheld by the Issuer to satisfy tax withholding requirements on vesting of restricted stock units.

SEC source: 0001415889-22-009540 · form4-09122022_020909.xml · nonDerivative · entry 1

Edwards Peter G · CIK 0001578376 · GENERAL COUNSEL

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,625

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units.

SEC source: 0001415889-22-009536 · form4-09122022_020937.xml · derivative · entry 3

Riebman Jerome · CIK 0001825821 · CHIEF MEDICAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Class A Common Stock · 14,758 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units.

F4 · derivative.exercise_date: The restricted stock units granted on March 8, 2022 vested in full on September 8, 2022.

F4 · derivative.expiration_date: The restricted stock units granted on March 8, 2022 vested in full on September 8, 2022.

SEC source: 0001415889-22-009536 · form4-09122022_020937.xml · nonDerivative · entry 2

Riebman Jerome · CIK 0001825821 · CHIEF MEDICAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,989

F3 · shares: Shares withheld by the Issuer to satisfy tax withholding requirements on vesting of restricted stock units.

SEC source: 0001415889-22-009536 · form4-09122022_020937.xml · nonDerivative · entry 1

Riebman Jerome · CIK 0001825821 · CHIEF MEDICAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,093

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units.

F2 · balance_after: Includes one share of the Issuer's Class A Common Stock acquired under the Issuer's 2020 Employee Stock Purchase Plan.

SEC source: 0001104659-22-073897 · tm2219201-1_4seq1.xml · derivative · entry 2

Mills C Randal · CIK 0001370939 · Director · Interim President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 182,511

Underlying: Class A Common Stock · 182,511 shares

Expires 2032-06-20

F2 · derivative.exercise_date: The option vests and becomes exercisable in four equal installments upon the Issuer's achievement of a share price equal to or greater than $12.50, $17.00, $25.00 and $37.00, in each case determined based on twenty consecutive days of trading at or above the applicable threshold, subject to the Reporting Person's continuous employment with the Issuer through the applicable vesting date.

SEC source: 0001104659-22-073897 · tm2219201-1_4seq1.xml · derivative · entry 1

Mills C Randal · CIK 0001370939 · Director · Interim President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 273,767

Underlying: Class A Common Stock · 273,767 shares

Expires 2032-06-20

F1 · derivative.exercise_date: The option vests and becomes exercisable as to one-third of the underlying shares upon the day following the expiration of the Interim Period (as defined in the Reporting Person's Employment Agreement dated June 21, 2022). The remaining two-thirds of the underlying shares vest and become exercisable, with respect to 25% of such shares, on June 21, 2023, and, with respect to 75% of such shares, in twelve equal quarterly installments thereafter, beginning on September 21, 2023, subject to the Reporting Person's continuous employment with the Issuer through the applicable vesting date.

SEC source: 0001415889-22-006330 · form4-06092022_050626.xml · derivative · entry 2

HighCape Capital, L.P. · CIK 0001826279 · Director · 10% owner

HIGHCAPE PARTNERS, L.P. · CIK 0001598046 · 10% owner

HIGHCAPE PARTNERS QP, L.P. · CIK 0001598026 · 10% owner

HighCape Partners GP, LLC · CIK 0001819933 · 10% owner

HighCape Partners GP, L.P. · CIK 0001819932 · 10% owner

HighCape Co-Investment Vehicle I, LLC · CIK 0001819988 · 10% owner

HighCape Co-Investment Vehicle II, LLC · CIK 0001820044 · Director · 10% owner

HighCape Capital, LLC · CIK 0001827500 · 10% owner

Zuga Matt · CIK 0001790214 · Director · 10% owner

RAKIN KEVIN · CIK 0001184421 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 22,090

Underlying: Class A Common Stock · 22,090 shares

Expires 2032-06-06

F1 · derivative.exercise_date: This option was granted automatically under the Issuer's Non-Employee Director Compensation Program and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to Messrs. Rakin's and Zuga's, as applicable, continuing in service on the Issuer's board of directors through the applicable vesting date.

F3 · ownership.nature: Held by W. Matthew Zuga as non-employee member of the Issuer's board of directors.

SEC source: 0001415889-22-006330 · form4-06092022_050626.xml · derivative · entry 1

HighCape Capital, L.P. · CIK 0001826279 · Director · 10% owner

HIGHCAPE PARTNERS, L.P. · CIK 0001598046 · 10% owner

HIGHCAPE PARTNERS QP, L.P. · CIK 0001598026 · 10% owner

HighCape Partners GP, LLC · CIK 0001819933 · 10% owner

HighCape Partners GP, L.P. · CIK 0001819932 · 10% owner

HighCape Co-Investment Vehicle I, LLC · CIK 0001819988 · 10% owner

HighCape Co-Investment Vehicle II, LLC · CIK 0001820044 · Director · 10% owner

HighCape Capital, LLC · CIK 0001827500 · 10% owner

Zuga Matt · CIK 0001790214 · Director · 10% owner

RAKIN KEVIN · CIK 0001184421 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 22,090

Underlying: Class A Common Stock · 22,090 shares

Expires 2032-06-06

F1 · derivative.exercise_date: This option was granted automatically under the Issuer's Non-Employee Director Compensation Program and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to Messrs. Rakin's and Zuga's, as applicable, continuing in service on the Issuer's board of directors through the applicable vesting date.

F2 · ownership.nature: Held by Kevin L. Rakin as non-employee member of the Issuer's board of directors.

SEC source: 0001415889-22-006336 · form4-06092022_050655.xml · derivative · entry 1

Mills C Randal · CIK 0001370939 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,090

Underlying: Class A Common Stock · 22,090 shares

Expires 2032-06-06

F1 · derivative.exercise_date: This option was granted automatically under the Issuer's Non-Employee Director Compensation Program and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person's continuing in service on the Issuer's board of directors through the applicable vesting date.

SEC source: 0001415889-22-006334 · form4-06092022_050640.xml · derivative · entry 1

Makes Brigid · CIK 0001375927 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,090

Underlying: Class A Common Stock · 22,090 shares

Expires 2032-06-06

F1 · derivative.exercise_date: This option was granted automatically under the Issuer's Non-Employee Director Compensation Program and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person's continuing in service on the Issuer's board of directors through the applicable vesting date.

SEC source: 0001415889-22-006332 · form4-06092022_050637.xml · derivative · entry 1

Jordan Maybelle · CIK 0001826123 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,090

Underlying: Class A Common Stock · 22,090 shares

Expires 2032-06-06

F1 · derivative.exercise_date: This option was granted automatically under the Issuer's Non-Employee Director Compensation Program and vests and becomes exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first annual meeting following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person's continuing in service on the Issuer's board of directors through the applicable vesting date.

SEC source: 0001104659-23-019991 · tm236492-1_4seq1.xml · nonDerivative · entry 1

Birchview Capital, LP · CIK 0001618205 · 10% owner

Birchview Fund LLC · CIK 0001603544 · 10% owner

Strobeck Matthew · CIK 0001377832 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,418,123

F1 · ownership.nature: Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC ("the Fund"). Birchview Capital, LP is the investment manager of the Fund.

F2 · ownership.nature: The Fund acquired the shares as specified in Table I. As investment manager of the Fund, Birchview Capital, LP possesses the power to vote and dispose or direct the disposition of the shares acquired by the Fund.

SEC source: 0001415889-22-002868 · form4-03102022_050356.xml · nonDerivative · entry 2

Englese Thomas · CIK 0001825799 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,607

F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.16 to $5.34. The Reporting Person undertakes to provide Aziyo Biologics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

SEC source: 0001415889-22-002860 · form4-03102022_050359.xml · derivative · entry 5

Ferguson Matthew · CIK 0001304079 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,874

Underlying: Class A Common Stock · 13,874 shares

Expires not disclosed

F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer Class A Common Stock.

F7 · derivative.exercise_date: The restricted stock units vest on September 8, 2022, subject to the Reporting Person's continuous employment with the Issuer through such vesting date.

F7 · derivative.expiration_date: The restricted stock units vest on September 8, 2022, subject to the Reporting Person's continuous employment with the Issuer through such vesting date.

SEC source: 0001415889-22-002860 · form4-03102022_050359.xml · derivative · entry 4

Ferguson Matthew · CIK 0001304079 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,862

Underlying: Class A Common Stock · 1,288 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into shares of Class A Common Stock on a one-for-one basis.

F6 · derivative.exercise_date: On March 8, 2021, the Reporting Person was granted 5,150 restricted stock units, vesting in four substantially equal annual installments beginning on March 8, 2022.

F6 · derivative.expiration_date: On March 8, 2021, the Reporting Person was granted 5,150 restricted stock units, vesting in four substantially equal annual installments beginning on March 8, 2022.